Corrigendum: Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder CancerYang He, Abai Xu, Boping Li et al.|Frontiers in Genetics|2022Cited by 1
A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC).Abai Xu, Chunxiao Liu, Peng Xu et al.|Journal of Clinical Oncology|2023Cited by 1
Corrigendum to “Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre” [Eur Urol 2022;82(5):543–550]Peng Xu, Abai Xu, Chunxiao Liu et al.|European Urology|2023Cited by 0